{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:26:48Z","timestamp":1792520808343,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>We previously reported that individuals with Parkinson\u2019s disease (PD) present with lower vitamin B3 levels compared to controls. It may be related to carbidopa interaction, defective tryptophan metabolism, and stresses of night sleep disorder. Vitamin B3 is the energy source for all cells by producing NAD<jats:sup>+<\/jats:sup> and NADP<jats:sup>+<\/jats:sup> in redox reactions of oxidative phosphorylation. Thus, some symptoms of PD such as fatigue, sleep dysfunction, and mood changes may be related to the deficiency of vitamin B3. Here, we conducted an effectiveness trial to determine the effect of 12 months of low-dose niacin (a vitamin B3 derivative) enhancement in PD individuals. An average of 9 \u00b1 6-point improvement in the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) III (motor) score was observed after 12 months of daily niacin compared to the expected decline in score (effect size = 0.78, 95% CI = 7\u201311). Additionally, secondary outcome measures improved. Notably, handwriting size increased, fatigue perception decreased, mood improved, frontal beta rhythm during quiet stance increased, and stance postural sway amplitude and range of acceleration decreased. Set shifting, however, as measured by the Trail Making-B test, worsened from 66 to 96 s. Other measures did not change after 12 months, but it is not clear whether this represents a positive benefit of the vitamin. For example, while the quality of night sleep remained the same, there was a trend towards a decrease in the frequency of awakening episodes. These results suggest that niacin enhancement has the potential to maintain or improve quality of life in PD and slow disease progression.<\/jats:p>","DOI":"10.3389\/fnagi.2021.667032","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T06:33:25Z","timestamp":1623911605000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Niacin Enhancement for Parkinson\u2019s Disease: An Effectiveness Trial"],"prefix":"10.3389","volume":"13","author":[{"given":"Raymond","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandramohan","family":"Wakade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Seamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banabihari","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"B35","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11357-020-00192-2","article-title":"A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson\u2019s disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study","volume":"42","author":"Calvani","year":"2020","journal-title":"GeroScience"},{"key":"B22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/15402002.2013.845782","article-title":"Validation of an automated wireless system for sleep monitoring during daytime naps","volume":"13","author":"Cellini","year":"2015","journal-title":"Behav. Sleep Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","article-title":"The Parkinson\u2019s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson\u2019s disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12967-018-1554-z","article-title":"The dimensionality of fatigue in Parkinson\u2019s disease","volume":"16","author":"Chong","year":"2018","journal-title":"J. Transl. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0022-510x(00)00277-x","article-title":"Parkinson\u2019s disease impairs the ability to change set quickly","volume":"175","author":"Chong","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"M129","DOI":"10.1093\/gerona\/54.3.m129","article-title":"Postural set for balance control is normal in Alzheimer\u2019s but not in Parkinson\u2019s disease","volume":"54","author":"Chong","year":"1999","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1742-1241.2012.02927.x","article-title":"Diagnostic value of the rapid assessment of postural instability in Parkinson\u2019s disease (RAPID) questionnaire","volume":"66","author":"Chong","year":"2012","journal-title":"Int. J. Clin. Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1468-1331.2010.03115.x","article-title":"Rapid assessment of postural instability in Parkinson\u2019s disease (RAPID): a pilot study","volume":"18","author":"Chong","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jnnp.47.5.443","article-title":"Cognitive and motor shifting aptitude disorder in Parkinson\u2019s disease","volume":"47","author":"Cools","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"B19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s004150050455","article-title":"Impairment of the supervisory attentional system in early untreated patients with Parkinson\u2019s disease","volume":"246","author":"Dujardin","year":"1999","journal-title":"J. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/jnnp.2011.240366","article-title":"The natural history of treated Parkinson\u2019s disease in an incident, community based cohort","volume":"82","author":"Evans","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"B26","volume-title":"Criteria for Distinguishing Effectiveness From Efficacy Trials in Systematic Reviews. Technical Review 12.","author":"Gartlehner","year":"2006"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.3390\/ijms20184559","article-title":"Niacin ameliorates neuro-inflammation in Parkinson\u2019s disease via GPR109A","volume":"20","author":"Giri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s11325-012-0757-4","article-title":"Assessment of a wireless headband for automatic sleep scoring","volume":"17","author":"Griessenberger","year":"2013","journal-title":"Sleep Breath."},{"key":"B36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1034\/j.1600-0404.2000.101003159.x","article-title":"Impaired cytokine production by peripheral blood mononuclear cells and monocytes\/macrophages in Parkinson\u2019s disease","volume":"101","author":"Hasegawa","year":"2000","journal-title":"Acta Neurol. Scand."},{"key":"B33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1162\/089892998562645","article-title":"Toward a functional analysis of the basal ganglia","volume":"10","author":"Hayes","year":"1998","journal-title":"J. Cogn. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1212\/wnl.47.3.644","article-title":"Diet and Parkinson\u2019s disease. II: a possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study","volume":"47","author":"Hellenbrand","year":"1996","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/mds.25684","article-title":"Objective biomarkers of balance and gait for Parkinson\u2019s disease using body-worn sensors","volume":"28","author":"Horak","year":"2013","journal-title":"Mov. Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing."},{"key":"B5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0014-2999(71)90195-6","article-title":"The effect of L-dopa on the concentrations of tryptophan, tyrosine and serotonin in rat brain","volume":"14","author":"Karobath","year":"1971","journal-title":"Eur. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.gaitpost.2012.04.010","article-title":"Postural sway as a marker of progression in Parkinson\u2019s disease: a pilot longitudinal study","volume":"36","author":"Mancini","year":"2012","journal-title":"Gait Posture"},{"key":"B20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/13803390902881942","article-title":"The trail making test and its neurobehavioral components","volume":"32","author":"Misdraji","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/wnl.42.9.1702","article-title":"Kynurenine pathway abnormalities in Parkinson\u2019s disease","volume":"42","author":"Ogawa","year":"1992","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"VII2","DOI":"10.1007\/s00415-006-7002-7","article-title":"The natural history of Parkinson\u2019s disease","volume":"253","author":"Poewe","year":"2006","journal-title":"J. Neurol."},{"key":"B21","volume-title":"The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation, 2nd edition.","author":"Reitan","year":"1993"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.3390\/s19122808","article-title":"Validation of electroencephalographic recordings obtained with a consumer-grade, single dry electrode, low-cost device: a comparative study","volume":"19","author":"Rieiro","year":"2019","journal-title":"Sensors"},{"key":"B4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cen3.12553","article-title":"Niacin for Parkinson\u2019s disease","volume":"11","author":"Seamon","year":"2020","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF02251205","article-title":"Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adeninedinucleotide (NADH)","volume":"5","author":"Vrecko","year":"1993","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/s0925-4439(97)00016-1","article-title":"NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaeochromocytoma cells","volume":"1361","author":"Vrecko","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"B34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2018.05.002","article-title":"Niacin modulates macrophage polarization in Parkinson\u2019s disease","volume":"320","author":"Wakade","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jns.2014.10.024","article-title":"A novel treatment target for Parkinson\u2019s disease","volume":"347","author":"Wakade","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ccr3.232","article-title":"Low-dose niacin supplementation modulates GPR109A levels and NAD\/NADH ratio and ameliorates PD symptoms","volume":"3","author":"Wakade","year":"2015","journal-title":"Clin. Case Rep."},{"key":"B1","doi-asserted-by":"publisher","first-page":"e109818","DOI":"10.1371\/journal.pone.0109818","article-title":"Upregulation of GPR109A in Parkinson\u2019s disease","volume":"9","author":"Wakade","year":"2014","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J. Psychiatr. Res."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.667032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T06:33:29Z","timestamp":1623911609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.667032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":37,"alternative-id":["10.3389\/fnagi.2021.667032"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.667032","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"article-number":"667032"}}